Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 864

1.

PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21).

Argani P, Antonescu CR, Couturier J, Fournet JC, Sciot R, Debiec-Rychter M, Hutchinson B, Reuter VE, Boccon-Gibod L, Timmons C, Hafez N, Ladanyi M.

Am J Surg Pathol. 2002 Dec;26(12):1553-66.

PMID:
12459622
2.

Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.

Argani P, Antonescu CR, Illei PB, Lui MY, Timmons CF, Newbury R, Reuter VE, Garvin AJ, Perez-Atayde AR, Fletcher JA, Beckwith JB, Bridge JA, Ladanyi M.

Am J Pathol. 2001 Jul;159(1):179-92.

3.

Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas.

Martignoni G, Pea M, Gobbo S, Brunelli M, Bonetti F, Segala D, Pan CC, Netto G, Doglioni C, Hes O, Argani P, Chilosi M.

Mod Pathol. 2009 Aug;22(8):1016-22. doi: 10.1038/modpathol.2009.58.

4.

Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR.

Argani P, Laé M, Hutchinson B, Reuter VE, Collins MH, Perentesis J, Tomaszewski JE, Brooks JS, Acs G, Bridge JA, Vargas SO, Davis IJ, Fisher DE, Ladanyi M.

Am J Surg Pathol. 2005 Feb;29(2):230-40.

PMID:
15644781
5.

Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay.

Argani P, Lal P, Hutchinson B, Lui MY, Reuter VE, Ladanyi M.

Am J Surg Pathol. 2003 Jun;27(6):750-61.

PMID:
12766578
6.
7.

The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.

Ladanyi M, Lui MY, Antonescu CR, Krause-Boehm A, Meindl A, Argani P, Healey JH, Ueda T, Yoshikawa H, Meloni-Ehrig A, Sorensen PH, Mertens F, Mandahl N, van den Berghe H, Sciot R, Dal Cin P, Bridge J.

Oncogene. 2001 Jan 4;20(1):48-57.

8.

Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions.

Martignoni G, Gobbo S, Camparo P, Brunelli M, Munari E, Segala D, Pea M, Bonetti F, Illei PB, Netto GJ, Ladanyi M, Chilosi M, Argani P.

Mod Pathol. 2011 Oct;24(10):1313-9. doi: 10.1038/modpathol.2011.93.

9.

Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations.

Altinok G, Kattar MM, Mohamed A, Poulik J, Grignon D, Rabah R.

Pediatr Dev Pathol. 2005 Mar-Apr;8(2):168-80.

PMID:
15747097
10.

A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23).

Argani P, Lui MY, Couturier J, Bouvier R, Fournet JC, Ladanyi M.

Oncogene. 2003 Aug 14;22(34):5374-8.

PMID:
12917640
11.

Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature.

Camparo P, Vasiliu V, Molinie V, Couturier J, Dykema KJ, Petillo D, Furge KA, Comperat EM, Lae M, Bouvier R, Boccon-Gibod L, Denoux Y, Ferlicot S, Forest E, Fromont G, Hintzy MC, Laghouati M, Sibony M, Tucker ML, Weber N, Teh BT, Vieillefond A.

Am J Surg Pathol. 2008 May;32(5):656-70. doi: 10.1097/PAS.0b013e3181609914.

PMID:
18344867
12.

Adult-onset renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusion with smooth muscle stroma and abnormal vessels.

Kuroda N, Tamura M, Tanaka Y, Hes O, Michal M, Inoue K, Ohara M, Mizuno K, Lee GH.

Pathol Int. 2009 Jul;59(7):486-91. doi: 10.1111/j.1440-1827.2009.02398.x.

PMID:
19563413
13.
14.

Transformation capacities of the papillary renal cell carcinoma-associated PRCCTFE3 and TFE3PRCC fusion genes.

Weterman MA, van Groningen JJ, den Hartog A, Geurts van Kessel A.

Oncogene. 2001 Mar 22;20(12):1414-24.

15.

Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas.

Weterman MA, Wilbrink M, Geurts van Kessel A.

Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15294-8.

16.

PRCC-TFE3 renal cell carcinoma in a boy with a history of contralateral mesoblastic nephroma.

Onder AM, Teomete U, Argani P, Toledano S, Zilleruelo G, Rodriguez MM.

Pediatr Nephrol. 2006 Oct;21(10):1471-5.

PMID:
16807766
17.

Renal cell carcinoma with t(X;17)(p11.2;q25) in a 6-year-old Taiwanese boy.

Chen CK, Hsueh C, Lai JY, Hung IJ, Whang-Peng J, Wang WP, Lai HY, Chen JR.

Virchows Arch. 2007 Feb;450(2):215-9.

PMID:
17149613
18.
19.

Imprint cytologic features in renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion in an adult: a case report.

Yamaguchi T, Kuroda N, Imamura Y, Hes O, Kawada T, Nakayama K.

Acta Cytol. 2009 Nov-Dec;53(6):693-7.

PMID:
20014561
20.

Renal cell carcinoma with rhabdoid features.

Gökden N, Nappi O, Swanson PE, Pfeifer JD, Vollmer RT, Wick MR, Humphrey PA.

Am J Surg Pathol. 2000 Oct;24(10):1329-38.

PMID:
11023094
Items per page

Supplemental Content

Support Center